A decade-long study found that obesity was associated with a significantly increased risk for biologic treatment failure in ...

Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 – LIfT ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...

We've all felt the instant relief of scratching an itch, but what if that fleeting moment of bliss was actually doing more ...

Krystal Biotech's shares have dropped 22% since July 2024 due to competition concerns. Read more to see a full investment ...

Africa's numerous cultures have long enjoyed a heritage of diets based on items known to be good for gut and metabolic health ...

Researchers conducted a randomized controlled trial in Tanzania to examine how switching between African heritage and Western ...

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...